Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies. | Front Genet | 2022 | 36003330 | PubTator, text mining | PubMed |
| Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from "first contact" interactions in the tumor microenvironment. | J Exp Clin Cancer Res | 2022 | 36002889 | PubTator, text mining | PubMed |
| [Research Progress of Acquired Resistance Mediated by MET Amplification in Advanced Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2022 | 36002199 | PubTator, text mining | PubMed |
| Intermediate filaments: Integration of cell mechanical properties during migration. | Front Cell Dev Biol | 2022 | 35990612 | PubTator, text mining | PubMed |
| Identification of molecular signatures associated with sleep disorder and Alzheimer's disease. | Front Psychiatry | 2022 | 35990086 | PubTator, text mining | PubMed |
| Utilisation of semiconductor sequencing for detection of actionable fusions in solid tumours. | PLoS One | 2022 | 35984852 | PubTator, text mining | PubMed |
| Central nervous system involvement of systemic ALK-positive histiocytosis with KIF5B-ALK fusion. | Radiol Case Rep | 2022 | 35982724 | PubTator, text mining | PubMed |
| RAB6 and dynein drive post-Golgi apical transport to prevent neuronal progenitor delamination. | EMBO Rep | 2022 | 35979738 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis. | Neoplasia | 2022 | 35964518 | PubTator, text mining | PubMed |
| Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial. | Nat Med | 2022 | 35962206 | PubTator, text mining | PubMed |
| Force generation of KIF1C is impaired by pathogenic mutations. | Curr Biol | 2022 | 35961316 | PubTator, text mining | PubMed |
| RET signaling pathway and RET inhibitors in human cancer. | Front Oncol | 2022 | 35957881 | PubTator, text mining | PubMed |
| Nitrosative stress in Parkinson's disease. | NPJ Parkinsons Dis | 2022 | 35953517 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| The ARSACS disease protein sacsin controls lysosomal positioning and reformation by regulating microtubule dynamics. | J Biol Chem | 2022 | 35933016 | PubTator, text mining | PubMed |
| Pericentrin interacts with Kinesin-1 to drive centriole motility. | J Cell Biol | 2022 | 35929834 | PubTator, text mining | PubMed |
| Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321). | Ther Adv Med Oncol | 2022 | 35923928 | PubTator, text mining | PubMed |
| Roles of mitochondrial genetics in cancer metastasis. | Trends Cancer | 2022 | 35915015 | PubTator, text mining | PubMed |
| Non-small-cell lung cancer: how to manage RET-positive disease. | Drugs Context | 2022 | 35912003 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=26